Posts

Showing posts with the label Primary Biliary Cirrhosis Drugs Market Report

Primary Biliary Cirrhosis Drugs Market | Trends,Size, Growth, Share, COVID-19 Impact ...

Image
  Primary biliary cirrhosis, known as primary biliary cholangitis is a chronic liver disease, which causes liver inflammation, fibrosis, and obstruction in the bile duct leading to destruction of small bile ducts within liver. Cause for primary biliary cirrhosis can be autoimmunity, infection and/or genetic predisposition. Symptoms of primary biliary cirrhosis includes itching, osteoporosis, elevated serum cholesterol, and malabsorption of fat and fat soluble vitamins, which can advance to hepatomegaly, hyperpigmentation, splenomegaly, jaundice, sicca syndrome or Kayser-Fleischer rings.  Primary biliary cirrhosis develops over time and may cause the liver to stop working completely in later stages. Most people are diagnosed early, before the disease progresses. Delay in treatment of cirrhosis can cause liver failure and a liver transplant is necessary for survival. Diagnostic tests for primary biliary cirrhosis includes examination of elevated levels of IgM immunoglobulin lev...

Popular posts from this blog

Vascular Ulcers Treatment focuses on keeping the wound site free of infection during the healing process and relieving edema

Hearing Protection Devices: Often Used To Prevent Noise-Induced Hearing Loss (NIHL)

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028